Most Read Articles
Rachel Soon, 12 Dec 2018

MIMS Pharmacist speaks to Cpt. Manvikram Singh Gill, military pharmacist with the Royal Medical and Dental Corps (RMDC) of the Malaysian Armed Forces (MAF),about his work at the Rohingya refugee camp in Cox's Bazar, Bangladesh.

Ms Penny Wong Pei Nee, 12 Jul 2018
Antibiotics, also known as antibacterials, are a group of medications that either destroy the infecting bacteria or slow down their growth.
Elaine Soliven, 30 Jun 2020
Treatment with Lactobacillus crispatus CTV-05 (Lactin-V) significantly reduces the incidence of bacterial vaginosis recurrence in women who were previously treated with vaginal metronidazole, according to a recent study.
Jairia Dela Cruz, 20 May 2020
Concomitant use of fimasartan and rosuvastatin in patients with hypertension and dyslipidaemia does not appear to be synergistic in increasing concurrent control rate of the diseases, although either drug is effective against the target disease, according to a study.

Voriconazole prophylaxis proven safe, effective in leukaemic patients with fungal infections

20 Jun 2020

Prophylaxis treatment with voriconazole appears to be safe and effective, with an efficacy comparable to literature data for risk of invasive fungal infection with posaconazole antifungal prophylaxis, in patients with acute leukaemia undergoing chemotherapy, reports a study.

In addition, voriconazole prophylaxis appears to represent a significant cost advantage.

The investigators performed a retrospective chart review on inpatients at Sunnybrook Health Sciences Centre in Toronto, Canada, between 2005 and 2017. They compared hospitalized adult acute leukaemia patients who received voriconazole prophylaxis (cases) to patients treated with fluconazole or no prophylaxis during chemotherapy (controls).

Statistical analyses were conducted to compare baseline characteristics, safety, and efficacy outcomes between the study cohorts. In addition, the investigators compared a literature-based weighted mean risk to the voriconazole risk of invasive fungal infection identified in this study.

A total of 490 acute myeloid leukaemia or acute lymphoblastic leukaemia patients were identified, of whom 92 cases and 83 controls met the eligibility criteria. Case patients received voriconazole prophylaxis for an average of 24.4±10.8 days.

Voriconazole resulted in a lower incidence of proven or probable invasive fungal infections compared with the control treatment (3.3 percent vs 7.2 percent; p>0.05). Such finding was comparable to the literature-reported weighted incidence of invasive fungal infection with posaconazole (2.4±2.1 percent, 95 percent confidence interval, 1.3–3.4 percent; p>0.05).

Of note, voriconazole was well tolerated by most patients (91 percent). Seven patients, however, discontinued treatment as a result of asymptomatic elevated liver function tests.

“Invasive fungal infections commonly occur in acute myeloid and lymphoblastic leukaemia patients receiving chemotherapy,” the investigators said. “In these patients with acute leukaemia, posaconazole prophylaxis is [usually] recommended.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 12 Dec 2018

MIMS Pharmacist speaks to Cpt. Manvikram Singh Gill, military pharmacist with the Royal Medical and Dental Corps (RMDC) of the Malaysian Armed Forces (MAF),about his work at the Rohingya refugee camp in Cox's Bazar, Bangladesh.

Ms Penny Wong Pei Nee, 12 Jul 2018
Antibiotics, also known as antibacterials, are a group of medications that either destroy the infecting bacteria or slow down their growth.
Elaine Soliven, 30 Jun 2020
Treatment with Lactobacillus crispatus CTV-05 (Lactin-V) significantly reduces the incidence of bacterial vaginosis recurrence in women who were previously treated with vaginal metronidazole, according to a recent study.
Jairia Dela Cruz, 20 May 2020
Concomitant use of fimasartan and rosuvastatin in patients with hypertension and dyslipidaemia does not appear to be synergistic in increasing concurrent control rate of the diseases, although either drug is effective against the target disease, according to a study.